Small-Molecule Drug Target Identification/Deconvolution Technologies

Similar documents
FRAUNHOFER IME SCREENINGPORT

Aims: -Purification of a specific protein. -Study of protein-protein interactions

Proteomics. Manickam Sugumaran. Department of Biology University of Massachusetts Boston, MA 02125

PDIP46 (DNA polymerase δ interacting protein 46) is an activating factor for human DNA polymerase δ

Kinetics Review. Tonight at 7 PM Phys 204 We will do two problems on the board (additional ones than in the problem sets)

IMMUNOPRECIPITATION TROUBLESHOOTING TIPS

T H E J O U R N A L O F C E L L B I O L O G Y

Reducing dynamic range with Proteominer

ENCODE DCC Antibody Validation Document

MagSi Beads. Magnetic Silica Beads for Life Science and Biotechnology study

NHS-Activated Agarose (Dry Form)

Solutions to 7.02 Quiz II 10/27/05

JCB. Supplemental material THE JOURNAL OF CELL BIOLOGY. Hong et al.,

Supplemental Figure 1

HOOK 6X His Protein Purification (Yeast)

fibrils, however, oligomeric structures and amorphous protein aggregates were

Partnered Discovery of High-Quality Antibody Drug Candidates. Company Presentation

Supplementary information

Recent Progress of Interprotein s Research Activities. Interprotein Corporation

Isolation of the recombinant middle and head + middle modules.

HOOK 6X His Protein Purification (Bacteria)

Purification of alpha-1 antitrypsin using an antibody based affinity chromatography medium

Post-translational modification

Description. Lipodin-Pro TM - Protein Transfection Reagent. 1. Kit Benefits

FSC-H FSC-H FSC-H

This Technical Note describes these characterization studies in more detail.

Application Note AN001

NPTEL VIDEO COURSE PROTEOMICS PROF. SANJEEVA SRIVASTAVA

Module Overview. Lecture

Amnis ImageStream : Technical Reports & Applications

Stable Isotope Labeling with Amino Acids in Cell Culture. Thermo Scientific Pierce SILAC Protein Quantitation Kits

SURFACE PLASMON RESONANCE-BASED SYSTEMS

HOOK 6X His Protein Spin Purification (Bacteria)

SUPPLEMENTARY INFORMATION. Small molecule activation of the TRAIL receptor DR5 in human cancer cells

Innovative Pharmaceutical Solutions for Discovery Chemistry, Biology and cgmp Manufacturing

(Refer Slide Time: 00:16)

Technical tips Session 5

Sulfhydryl Immobilization Kit for Proteins

Motivation From Protein to Gene

Module Overview. Lecture. DNA library synthesis (PCR) Introduction

Li et al., Supplemental Figures

Heating up the target deconvolution strategies: thermal proteome profiling for identification of drug targets

Case Studies ZoBio

Glutathione Resin. (Cat. # , , , ) think proteins! think G-Biosciences

Supplementary Materials for

Microarray Industry Products

Nature Structural & Molecular Biology: doi: /nsmb.1583

Supporting information. Single-cell and subcellular pharmacokinetic imaging allows insight into drug action in vivo

Supplementary Infomation

One-Step Western TM Kit using TMB

For the quick and efficient purification of highly specific and ultra pure antibodies

Supplementary Information

Isolation of Protein

20.320, notes for 9/13

Cat. No. MG17PG-1ml XPRESSAFFINITY PROTEIN G- MAGNETIC NANOPARTICLES (MNP) FOR RESEARCH APPLICATIONS

Fig. 1. A schematic illustration of pipeline from gene to drug : integration of virtual and real experiments.

SONOMA STATE UNIVERSITY DEPARTMENT OF BIOLOGY BIOLOGY 344: CELL BIOLOGY Fall 2013

Phos-tag beads as an immunoblotting enhancer for selective detection of phosphoproteins in cell lysates

The Confo body technology, a new platform to enable fragment screening on GPCRs

Identification of Unknown Target Antigens using PhyNexus Technology. Claudia Fieger Tim Hotaling June 2, 2009 June 4, 2009

Supplementary Figure 1. α-synuclein is truncated in PD and LBD brains. Nature Structural & Molecular Biology: doi: /nsmb.

Name with Last Name, First: BIOE111: Functional Biomaterial Development and Characterization MIDTERM EXAM (October 7, 2010) 93 TOTAL POINTS

Question 2 (15 points)

Enabling Lead Discovery at Epigenetics Targets with RapidFire Mass Spectrometry

SUPPLEMENTARY INFORMATION

Glutathione Resin. (Cat. # , , , ) think proteins! think G-Biosciences

SUPPLEMENTARY INFORMATION

The World Leader in SPR Technology. Jimmy Page, PhD, Biacore, Inc.

Supplementary information, Figure S1A ShHTL7 interacted with MAX2 but not another F-box protein COI1.

Custom Antibody Services. Antibodies Designed Just for You. HuCAL Recombinant Monoclonal Antibody Generation Service

NPTEL VIDEO COURSE PROTEOMICS PROF. SANJEEVA SRIVASTAVA

Cytomics in Action: Cytokine Network Cytometry

In Vitro Pharmacology Services

Immobilized Streptavidin Resin

Peptide enrichment and fractionation

BioFarma USEF. Expertise in drug discovery projects

Understanding life WITH NEXT GENERATION PROTEOMICS SOLUTIONS

Rer1 and calnexin regulate endoplasmic reticulum retention of a peripheral myelin protein 22 mutant that causes type 1A Charcot-Marie-Tooth disease

Alternative to 2D gel electrophoresis OFFGEL electrophoresis combined with high-sensitivity on-chip protein detection.

An Automated, Cell-based Platform for the Rapid Detection of Novel Androgen Receptor Modulators

Why purify proteins?

Attenuation of synaptic toxicity and MARK4/PAR1-mediated Tau phosphorylation by

PEER REVIEW FILE. Reviewers' Comments: Reviewer #2 (Remarks to the Author):

Newsletter Issue 7 One-STrEP Analysis of Protein:Protein-Interactions

SUPPLEMENTARY INFORMATION FILE

SUPPLEMENTARY INFORMATION

Pro-DeliverIN TM - Protein Delivery Reagent Results

Lecture 5: 8/31. CHAPTER 5 Techniques in Protein Biochemistry

The use of target immobilised NMR screening to identify and develop fragment binders to Hsp90

ab CytoPainter Mitochondrial Staining Kit NIR Fluorescence

Hossain_Supplemental Figure 1

RayBio Human NF-κB p65 Transcription Factor Activity Assay Kit

Supplemental Information. Pacer Mediates the Function of Class III PI3K. and HOPS Complexes in Autophagosome. Maturation by Engaging Stx17

MSD Immuno-Dot-Blot Assays. A division of Meso Scale Diagnostics, LLC.

Application Manual ProteoSpin Abundant Serum Protein Depletion Kit

T H E J O U R N A L O F C E L L B I O L O G Y

Supplementary Figure 1. GST pull-down analysis of the interaction of GST-cIAP1 (A, B), GSTcIAP1

CBI Toolbox Tour 2015

B Western blot of the p150caf-1 complex

Immunoaffinity Chromatography

Transcription:

Small-Molecule Drug Target Identification/Deconvolution Technologies Case-Studies

Shantani Target ID Technology Tool Box Target Deconvolution is not Trivial = A single Tool / Technology May Not necessarily solve the problem Our Focus = Target ID UPT We Utilize Several Proprietary and Generic Technologies for Right Target COMP TPP Target ID TBB SCLS 1) UPT = Unique Polymer Technology, 2) SCLS = Subcellular Location Specific Target Capture Technology, 3) COMP = in-silico target ID workflows, 4) TBB = Traditional Bead/Biotinylated Molecule Based Method, 5) TPP = Thermal Proteome Profiling

Case Study # 1: A Drug Discovery Program from a Seattle, USA based Organization Scenario Phenotypically Screened Hit compound, Target not known, Hit can not be rationally optimized For Target ID Typical bead/biotinylation based affinity chromatography can not be performed because Molecule is not easy to derivatize Shantani s Solution Shantani s Proprietary Unique Polymer Technology that can immobilize underivatized molecule for affinity chromatography Eventually Target(s) that can be linked to observed phenotype were identified

Unique Polymer Technology (UPT) Uniqueness Typical Target ID Workflow 1. Molecule Derivatization not needed. 2. Target Identification can be completed in 2-3 weeks. Working Principle Molecule transiently get immobilized on Specifically Engineered Polymeric Surface through multiple non-covalent interaction with Polymer. Thus formed molecule specific affinity matrix is used in capturing the target from cell-lysates.

Case # 1: Client provided 9 mg of Lysate + 15 mg of Molecule Shantani used UPT 1 month Deconvoluted Targets Typical SDS-PAGE Separated Protein Profile from Control and Molecule Loaded Matrix Typical Target Deconvolution Process Eventual Value and GO Decision Information of Target was used for Action Mechanism Analysis and few targets were shortlisted for validation

Case Study # 2: A Large Indian Corporate looking for new regenerative medicine Scenario Bioactive compound, at lower concentration induces proliferation of cells but at 20X concentration induced cell death Target not known/moa not clear Hit can not be rationally optimized Some structure-activity relationship data available but no path forward. Shantani s Solution Shantani was consulted for Project Shantani used traditional bead based (TBB) methods and identified the targets in-silico target validation was performed and targets were rank ordered based on predicted Kd values Identified targets with predicted lower affinity were linked with cell-death and higher affinity (strong affinity) with proliferation

Traditional Bead Based Methodology (TBB) Uniqueness Typical Target ID Workflow Can identify targets having broad range of affinity with molecule (Kd ~ nanomolar to micromolar) Working Principle Molecules are immobilized on the solid support to prepare molecule specific affinity matrix. Affinity chromatography is carried out from relevant cell-lysate to capture the target proteins on solid support. Later captured proteins are identified using massspectrometry and deconvoluted.

Case # 2: Client Compound Combinatorial Library Shantani (5 weeks) Shantani (2 weeks) Shantani (3 weeks) SAR analysis & Synthesis of primary amine derivative Confirmation of functional activity of derivatized molecule Target Identification, insilico target validation & MOA analysis Eventual Value and GO Decision Molecules selectivity was optimized over identified target proteins that were linked to cell death Identified proteins (red circled) with predicted higher kd were involved in cell death and with lower kd were linked to proliferation.

Case Study # 3: A European SME Scenario Phenotypically Screened Hit compound, Target not known, Hit can not be rationally optimized For Target ID Typical bead/biotinylation based affinity chromatography can not be performed because a slight change in molecular structure looses the activity of the compound Shantani s Solution Shantani s Proprietary Unique Polymer Technology that can immobilize underivatized molecule for affinity chromatography Eventually Target(s) that can be linked to observed phenotype were identified

Case # 3: Client Shantani (1 week) Shantani (1 week) Shantani (1 week) Hit compound Preparation of affinity matrix using UPT Affinity Chromatography and Target ID Target Deconvolution Total Proteins Identified = 253 Deconvoluted Specific Target = 5 Protein Class / Name Specificity Ratio Methyl Transferase 1 Fibronectin Binding Protein 1 Mitochondrial Transport Protein 1 GTPase activating Protein 1 Adapter Protein for T-Cell Signalling 1 Eventual Value and GO Decision Typical Enrichment of the Target in Direct Load Experiment Silver Stain Profile Identified a Novel Epigenetic Target Target was validated by client using overexpression and Binding Studies

Case Study # 4: A Internal Study Scenario Molecule Bisindolylmaleimide-III (Bis-III) interacts with GSK3-β and induce apoptosis GSK3-β is present both in cytoplasm and nucleus. For clarity on MOA and newer compound design location of target is needed SAR of the Bis-III molecule is well-established Shantani s Solution Shantani s Proprietary subcellular location specific target capturing target methodology Target location was identified and for conformation target was captured from specific sub-cellular location

Subcellular Location Specific Target Identification Technology (SCLS) Uniqueness 1. Very low false positive identification rate ~20% 2. Can identify targets in subcellular location specific manner in a live-cell set-up Working Principle 1) Bait molecules are coupled to proprietary sub-cellular location specific probes 2) These probes in separate experiments drag the molecule in different specific sub-cellular locations and functional activity of the molecule is measured 3) Sub-cellular location that shows maximum activity is chosen as target-rich compartment and target captures experiments are performed from target-rich locations Cytoplasmic Probe Nuclear Probe Membrane Probe

Case # 4: Sub-cellular Location Specific Functional Activity of Bis-III Probes Bis-III was coupled to three sub-cellular location specific proprietary peptides Cytotoxic Assay in HeLa Cells Bis-compound and all probes and control probes at 80 µm concentration. Bis-III probes that were targeted to the nucleus exhibited similar activity as the free Bis-III Target located in nucleus is responsible for the activity

Case # 4. Capture of Target from Nuclear Fractions Probes = Coupled with Bis-III Probes + Nuclear Fractions of He La Cells Probe Elution Control Probe Elution Nuclear Fractions (diluted) Incubation with probe antibody Washing of antibody GSK3-beta Western Blot Analysis of Elution for Target Protein Target was specifically captured with Probe. Eventual Value and GO Decision Establishing sub-cellular location of the target clarified the MOA and new compound design included the additional parameters that molecule should target nucleus

Case Study # 5 Identification of Target Using Computational Approaches Scenario Several Computational Approaches are available for identifying the Targets of Small Molecule that utilizes structural information of the molecule and compares it with the historical database (similar structure + Target) These approaches generate a long list of targets (most of them are false positive) and a few target for validation can not be prioritized Shantani s Solution Shantani s Proprietary computational approach identify a few but the rightful target

Case # 5: Deconvolution of Targets of a Few Known Small Molecules using Shantani s COMP workflow Bisindolylmaleimide-III BMS-345541 # of Target Identified # of Actual Target (Kd < 500 nm) Success Ratio (Total / Actual Target) Algorithm-1 26 1 4% Algorithm-2 4 2 50% Algorithm-3 16 2 13% Shantani-Algorithm 2 1 (Identified Target =PKC-α) # of Target Identified # of Actual Target (Kd < 500 nm) 50% Success Ratio (Total / Actual Target) Algorithm-1 17 1 6% Algorithm-2 8 2 25% Algorithm-3 19 2 11% Shantani-Algorithm 2 1 (Identified Target =IKK-β) 50% Eventual Value and GO Decision Shantani s COMP workflow allows identification of a few but rightful targets

Connect for further discussions Saba Naaz Siddique saba@shantani.com Phone: +91-20-64103918 http://